Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1243 of 5804
-
New oral drug aims to tame severe eczema in teens
Disease control CompletedTo evaluate the population pharmacokinetic characteristics of QY201 Tablets in adolescent participants with moderate to severe atopic dermatitis (AD).
Phase: PHASE2 • Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Blindfold treadmill training shows promise for stroke rehab
Symptom relief Recruiting nowObjective: The aim of this study is to compare the efficiency of vision-obscured versus vision-retained treadmill gait training in subacute post-stroke patients. Methodology: Thirty-six patients with stroke (ischemic or hemorrhagic) less than six months old will be included and …
Phase: NA • Sponsor: Centre Hospitalier Régional Metz-Thionville • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New drug cocktail targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThe trial consists of Stage 1 (including dose escalation and dose expansion) and Stage 2 (proof-of-concept study). Among them, Stage 2 adopts a randomized, controlled, open-label, and multicenter design.
Phase: PHASE2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
Wearable tech aims to boost exercise and quality of life in cancer patients
Symptom relief Recruiting nowThis clinical trial compares the effect of an automated personalized physical activity intervention supported by wearable technology to standard of care on physical activity levels and quality of life in patients with stage II- IV ovarian, primary peritoneal, fallopian tube cance…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Could a 2-Week radiation course replace longer treatment for skin cancer?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate if short-course radiation therapy (SCRT) can effectively treat high-risk cutaneous squamous cell carcinoma (cSCC) and if active surveillance is a safe alternative to radiation for moderate-risk cSCC in adults with head and neck cSCC …
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New Four-Pronged antibody takes aim at lupus
Disease control Recruiting nowThis study is a randomized, controlled, phase I clinical study with safety, efficacy, and pharmacokinetic/pharmacodynamic characteristics in patients with systemic lupus erythematosus.
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could fasting help the immune system fight prostate cancer?
Knowledge-focused Recruiting nowActivating the immune system to kill cancer cells is a promising therapeutic strategy for some patients with cancer. Unfortunately, current immune-targeting treatments do not work for patients with prostate cancer. In animal models of cancer, fasting can reprogram the body's meta…
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Blood test may spot liver cancer risk years early in cirrhosis patients
Diagnosis Recruiting nowThis study aims to evaluate the role of the circulating epigenetic biomarker mSEPT9 in predicting the risk of hepatocellular carcinoma (HCC) in patients with cirrhosis. HCC is a primary liver cancer that frequently develops in individuals with cirrhosis, and early detection is cr…
Sponsor: Central Hospital, Nancy, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New heart device aims to tame stubborn AFib
Disease control Recruiting nowThe ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for Crohn's: experimental drug SAR442970 enters phase 2 trial
Disease control Recruiting nowThis is a phase 2b, randomized, double-blind, 3-arm study for the treatment of Crohn's disease. The primary objective of this study is to assess the efficacy of different doses of SAR442970 compared with placebo in participants with moderate to severe Crohn's disease. The total s…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could 3 radiation doses beat 4 for cervical cancer?
Disease control Recruiting nowThis is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Could a diabetes drug curb opioid cravings? new study investigates
Disease control Recruiting nowThe is a pilot, 12-week, double-blind, placebo-controlled, randomized trial of individuals with opioid use disorder (OUD) newly initiating buprenorphine to receive either weekly injections of semaglutide (n=23) or matching placebo (n=23). The primary aim is to determine the effec…
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
One-and-done surgery for stubborn bone infections? new study puts bone filler to the test.
Disease control Recruiting nowThe study is a prospective cohort study of subjects where CERAMENT G was used as part of the surgical treatment of osteomyelitis in a single stage procedure.
Sponsor: BONESUPPORT AB • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Gene test before kidney transplant could prevent drug dosing errors
Disease control Recruiting nowThis is a phase IV multicentre adaptive single-blinded randomized clinical trial to evaluate if preemptively genotyping populations at pretransplant chronic kidney disease susceptible of receiving tacrolimus therapy is effective, cost-effective, and feasible within the Spanish Na…
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Jun 26, 2026 16:21 UTC
-
New pill aims to stop hearing loss from lifesaving antibiotics
Prevention Recruiting nowThe goal of this clinical trial is to test the effectiveness of the study drug, ORC-13361, in preventing hearing loss in patients with NTM infection who are undergoing treatment with IV amikacin therapy. The main question this study aims to answer is: * Is ORC-13661 effective fo…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC
-
Could a diabetes drug help heart failure patients with valve replacements?
Disease control CompletedThis study evaluates whether adding a medication called semaglutide to an existing treatment of dapagliflozin provides better outcomes for patients with heart failure who have previously undergone surgical heart valve replacement. Dapagliflozin is already a standard treatment fo…
Phase: PHASE2 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to speed up treatment for blood cancer patients
Disease control Recruiting nowThis phase II trial studies the side effects of an escalated ramp-up of sonrotoclax following initial debulking with zanubrutinib or rituximab in treating patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL) that is ne…
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a sleep app save teen lives? new study aims to find out
Symptom relief Recruiting nowThe purpose of this research study is to compare (vs. treatment as usual) a brief (6-session), empirically supported, and highly disseminable version of digital (i.e., smartphone or web-based) cognitive behavioral therapy for insomnia (dCBT-I), called SleepioTM, in suicidal adole…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New hope for ulcerative colitis: experimental drug OD-07656 enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC). In addition, the study will evaluate the potential of OD-07656 to enhance the therapeutic benefit of vedolizumab when …
Phase: PHASE2 • Sponsor: Odyssey Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Tongue zaps may boost arm recovery after stroke
Symptom relief Recruiting nowFollowing a stroke, persistent residual muscle weakness in the upper limb (UL) drastically impacts the individuals' quality of life and level of independence. Training interventions are recommended to promote UL motor recovery, and recent studies have shown that training must be …
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC